Browse > Article
http://dx.doi.org/10.14407/jrpr.2020.00276

Secondary Neutron Dose in Carbon-ion Radiotherapy: Investigations in QST-NIRS  

Yonai, Shunsuke (Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, Quantum Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology)
Matsumoto, Shinnosuke (Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, Quantum Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology)
Publication Information
Journal of Radiation Protection and Research / v.46, no.2, 2021 , pp. 39-47 More about this Journal
Abstract
Background: The National Institutes for Quantum and Radiological Science and Technology-National Institute of Radiological Sciences (QST-NIRS) has continuously investigated the undesired radiation exposure in ion beam radiotherapy mainly in carbon-ion radiotherapy (CIRT). This review introduces our investigations on the secondary neutron dose in CIRT with the broad and scanning beam methods. Materials and Methods: The neutron ambient dose equivalents in CIRT are evaluated based on rem meter (WENDI-II) measurements. The out-of-field organ doses assuming prostate cancer and pediatric brain tumor treatments are also evaluated through the Monte Carlo simulation. This evaluation of the out-of-field dose includes contributions from secondary neutrons and secondary charged particles. Results and Discussion: The measurements of the neutron ambient dose equivalents at a 90#x00B0; angle to the beam axis in CIRT with the broad beam method show that the neutron dose per treatment dose in CIRT is lower than that in proton radiotherapy (PRT). For the scanning beam with the energy scanning technique, the neutron dose per treatment dose in CIRT is lower than that in PRT. Moreover, the out-of-field organ doses in CIRT decreased with distance to the target and are less than the lower bound in intensity-modulated radiotherapy (IMRT) shown in AAPM TG-158 (American Association of Physicists in Medicine Task Group). Conclusion: The evaluation of the out-of-field doses is important from the viewpoint of secondary cancer risk after radiotherapy. Secondary neutrons are the major source in CIRT, especially in the distant area from the target volume. However, the dose level in CIRT is similar or lower than that in PRT and IMRT, even if the contributions from all radiation species are included in the evaluation.
Keywords
Carbon-ion Radiotherapy; Neutron; Out-of-Field Dose; WENDI-II; PHITS;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee C, Lodwick D, Hurtado J, Pafundi D, Williams JL, Bolch WE. The UF family of reference hybrid phantoms for computational radiation dosimetry. Phys Med Biol. 2010;55:339-363.   DOI
2 Durante M. New challenges in high-energy particle radiobiology. Br J Radiol. 2014;87:20130626.   DOI
3 Pompos A, Durante M, Choy H. Heavy ions in cancer therapy. JAMA Oncol. 2016;2:1539-1540.   DOI
4 Brenner DJ, Hall EJ. Secondary neutrons in clinical proton radiotherapy: a charged issue. Radiother Oncol. 2008;86:165-170.   DOI
5 Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer. 2011;11: 438-448.   DOI
6 National Council on Radiation Protection and Measurements. Second primary cancers and cardiovascular disease after radiation therapy (Report No. 170). Bethesda, MD: National Council on Radiation Protection and Measurements; 2011.
7 Farah J, Mares V, Romero-Exposito M, Trinkl S, Domingo C, Dufek V, et al. Measurement of stray radiation within a scanning proton therapy facility: EURADOS WG9 intercomparison exercise of active dosimetry systems. Med Phys. 2015;42:2572-2584.   DOI
8 Yonai S, Matsufuji N, Kanai T, Matsui Y, Matsushita K, Yamashita H, et al. Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies. Med Phys. 2008; 35:4782-4792.   DOI
9 Yonai S, Furukawa T, Inaniwa T. Measurement of neutron ambient dose equivalent in carbon-ion radiotherapy with an active scanned delivery system. Radiat Prot Dosimetry. 2014;161:433-436.   DOI
10 Yonai S, Matsufuji N, Akahane K. Monte Carlo study of out-offield exposure in carbon-ion radiotherapy with a passive beam: organ doses in prostate cancer treatment. Phys Med. 2018;51: 48-55.   DOI
11 Matsumoto S, Yonai S. Evaluation of neutron ambient dose equivalent in carbon-ion radiotherapy with energy scanning. Radiat Prot Dosimetry. 2020;191:310-318.   DOI
12 Kawachi K, Kanai T, Matsuzawa H, Inada T. Three dimensional spot beam scanning method for proton conformation radiation therapy. Acta Radiol Suppl. 1983;364:81-88.
13 Yonai S, Kase Y, Matsufuji N, Kanai T, Nishio T, Namba M, et al. Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies. Med Phys. 2010;37:4046-4055.   DOI
14 International Electrotechnical Commission. Medical electrical equipment - Part 2-64: Particular requirements for the basic safety and essential performance of light ion beam medical electrical equipment. Geneva, Switzerland: International Electrotechnical Commission; 2014. IEC 60601-2-64:2014.
15 Menzel HG, Clement C, DeLuca P. ICRP Publication 110: Realistic reference phantoms: an ICRP/ICRU joint effort. A report of adult reference computational phantoms. Ann ICRP. 2009;39: 1-164.
16 Tsujii H, Kamada T. A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol. 2012;42:670-685.   DOI
17 Halperin EC. Particle therapy and treatment of cancer. Lancet Oncol. 2006;7:676-685.   DOI
18 Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25:953-964.   DOI
19 Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1-7.   DOI
20 Sato T, Iwamoto Y, Hashimoto S, Ogawa T, Furuta T, Abe SI, et al. Features of particle and heavy ion transport code system (PHITS) version 3.02. J Nucl Sci Technol. 2018;55:684-690.   DOI
21 International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21:1-201.   DOI
22 Olsher RH, Hsu HH, Beverding A, Kleck JH, Casson WH, Vasilik DG, et al. WENDI: an improved neutron rem meter. Health Phys. 2000;79:170181.
23 Haberer T, Becher W, Schardt D, Kraft G. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res A. 1993;330:296-305.   DOI
24 Matsumoto S, Yonai S, Bolch WE. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment. Med Phys. 2019;46:5824-5832.   DOI
25 Stokkevag CH, Schneider U, Muren LP, Newhauser W. Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy. Phys Med. 2017;42:259-262.   DOI
26 Kry SF, Bednarz B, Howell RM, Dauer L, Followill D, Klein E, et al. AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phys. 2017;44:e391-e429.   DOI
27 Yonai S, Matsufuji N, Namba M. Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation. Med Phys. 2012;39:5028-5039.   DOI
28 Schneider U, Agosteo S, Pedroni E, Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244-251.   DOI
29 Furukawa T, Hara Y, Mizushima K, Saotome N, Tansho R, Saraya Y, et al. Development of NIRS pencil beam scanning system for carbon ion radiotherapy. Nucl Instrum Methods Phys Res B. 2017;406:361-367.   DOI